Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer
-
Published:2024-09
Issue:9
Volume:42
Page:290.e11-290.e16
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Ingram Justin W.ORCID,
Chung Rainjade,
Laplaca Caroline,
McKiernan James M.,
Lenis Andrew T.,
Anderson Christopher B.ORCID
Reference15 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Management, surveillance patterns, and costs associated with low-grade papillary stage ta non–muscle-invasive bladder cancer among older adults, 2004-2013;Bree;JAMA Netw Open,2022
3. Anderson CB, McKiernan JM. 80 - tumors of the urethra.
4. Extravesical tumor relapse in patients with superficial bladder tumors;Herr;J Urol,1998
5. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with Bacillus Calmette-Guérin;Palou;Eur Urol,2012